Forward Pharma(FWPAY) - 2018 Q4 - Annual Report

Use these links to rapidly review the document TABLE OF CONTENTS Index to Consolidated Financial Statements Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F | (Mark | | | --- | --- | | One) | | | o | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT | | | OF 1934 | | | OR | | ý | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the fiscal year ended December 31, 2018 | | | OR ...